NEW YORK (July 18, 2019) – The Hereditary Disease Foundation (HDF), which funds scientific research to find treatments and cures for Huntington’s disease, announced that Barry H. Evenchick, has been elected to its Board of Directors.  

Nancy Wexler, President of HDF, said, “We are thrilled

that Barry is joining our Board. His wisdom and

guidance will be invaluable as we continue our work to

fund innovative research that is advancing our

understanding of Huntington’s disease and bringing

hope to families who are affected by this devastating

genetic disorder.” 

Mr. Evenchick is a partner at the New Jersey-based law

firm Pashman Stein Walder Hayden where his practice

focuses on litigation. He is a former prosecutor, having

served as chief of the appellate section of the Essex

County Prosecutor’s Office and as the first chief of the

appellate section of the New Jersey Division of Criminal

Justice. He also served for 12 years as the municipal

attorney of the Township of Livingston and for six years

as a commissioner of the New Jersey State Commission of Investigation. He is an adjunct faculty member of Rutgers Law School in Newark and serves as vice-chair of the editorial board of the New Jersey Law Journal. 

“I am honored and proud to be elected to the Board of the Hereditary Disease Foundation,” Mr. Evenchick said. “I look forward to working with my fellow Board members as we further our efforts to support research that is making a difference in the lives of Huntington’s disease patients and their families.” 

About the Hereditary Disease Foundation
The Hereditary Disease Foundation facilitates collaborative and innovative scientific research to further the understanding of Huntington’s disease, a genetic disorder that strikes in early- to mid-adulthood, destroying brain cells and bringing on severe and progressive declines in personality, cognitive ability, and mobility. As a disease caused by a mistake on a single gene, Huntington’s disease is an ideal model for other brain disorders. Research organized by the Foundation led to the discovery of the genetic marker for Huntington’s disease in 1983. HDF organized and funded a decade-long international collaboration of over 100 scientists who discovered the gene that causes Huntington’s in 1993. This work played an important role in the development of the Human Genome Project. For information, visit

About Pashman Stein Walder Hayden
Pashman Stein Walder Hayden is a full-service business law firm offering a wide range of corporate and personal legal services. Headquartered in Hackensack, New Jersey with offices in Monmouth County, New Jersey, and Westchester County, New York, the firm serves a diverse client base including regional Fortune 500 companies, emerging growth entities, and individuals, as well as out-of-state corporate counsel, law firms, and individuals with interests in the New York metropolitan region. Named a Regional Powerhouse in 2018 by Law360 and awarded Appellate Litigation Department of the Year (2018) by the New Jersey Law Journal and recognized by Chambers USA 2018 as one of the top law firms in New Jersey in the fields of General Commercial Litigation and White-Collar Crime & Government Investigations, Pashman Stein and its lawyers continue to be recognized for sophisticated legal skills and experience. For more information, visit

Barry H. Evenchick

Barry H. Evenchick, Partner at Pashman Stein Walder Hayden, Elected to Board of the Hereditary Disease Foundation